We are investigating how dapagliflozin, alone or with balcinrenone, affects kidney function and fluid balance in people over 50 with chronic kidney disease. This study aims to understand the potential benefits of these treatments on energy metabolism and urine concentration.
Health conditions and diseases that the clinical trial is designed to study and treat.
Stage 3 chronic kidney disease (CKD) is a condition where the kidneys are moderately damaged, leading to a decline in their ability to filter waste from the blood. Patients may experience symptoms such as fatigue, swelling, and changes in urination.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.